A multitude of new COPD products have been PBS-listed over the last few years. This educational visit offered a structured approach to help clarify where the newer options, including fixed-dose combination inhalers, fit within the latest COPD-X management guidelines.
CPD Points
Accredited by RACGP for 2 (Category 2) points
Toggle informationEducational visit
This activity has been approved for 2 (Category 2) points in the RACGP QI & CPD Program for the 2017 - 2019 triennium (activity number 92387).
Small-group case-based meeting
This activity has been approved for 2 (Category 2) points in the RACGP QI & CPD Program for the 2017 - 2019 triennium (activity number 92395).
Accredited by ACRRM for 1 Core point
Toggle informationEducational visit
This activity has been accredited for 1 Core point in the ACRRM PD Program for the 2017-2019 triennium (activity code 7117).
Small-group case-based meeting
This activity has been accredited for 1 Core point in the ACRRM PD Program for the 2017-2019 triennium (activity code 7118).
About
A multitude of new COPD products have been PBS listed over the last few years.
This program offers a structured approach to help clarify where the newer options, including fixed-dose combination inhalers, fit within the latest COPD-X management guidelines.
Book a one-on-one or small-group case-based educational visit and receive a Lung Foundation Australia resource with a stepwise guide to managing COPD. Plus access to patient fact sheets on spirometry and inhaler technique checklists for a range of devices.
If your practice is enrolled in our MedicineInsight program, your visit will be tailored to discuss your practice data.
Learning outcomes
1. Describe the importance of spirometry in the diagnosis of COPD, and prior to commencing an ICS + LABA FDC.
2. Utilise the Stepwise Management of Stable COPD chart to implement a systematic approach to achieve symptom control in patients.
3. Choose inhaled medicines to treat COPD based on potential benefits, safety profile and patient preference.
4. Describe and discuss with patients the key considerations that may influence choice of inhaler device.